AzTrials
AzTrials

Quality of LifeNCT05862662

Mobility Opportunities Via Education/Experience (MOVE): Healthcare Impact Assessment

An observational study of Quality of Life and Health Care Utilization, run by Center for Disability Services, New York at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether participation in the Mobility Opportunities Via Education (MOVE) program is associated with reduced use of healthcare for individuals with developmental disabilities. Read more about this study

Who is it for?
Ages 5 to 65 years
Conditions the study is for
Quality of Life, Health Care Utilization
What is being tested?
MOVE Program
How many people
130 participants
Where
1 siteUnited States
Study dates
3 Apr 2023to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Children and adults with developmental disabilities who participated in the MOVE program for at least one year pre-COVID and are participating in the MOVE program post-COVID, but who did not participate in the MOVE program during COVID.

CHILDREN: Inclusion Criteria

  • Males and females 5-21 years old.
  • Participated in the MOVE program pre-COVID and post-COVID.
  • Did not participate for at least 4 months in the MOVE program during COVID.
  • Has a healthcare payor(s) who makes healthcare records available upon request.
  • Subjects whose legal guardians are willing to give informed consent to obtain and review healthcare records from the subject's primary (and secondary, if applicable) payors.

CHILDREN: Exclusion Criteria

  • Subjects who did not participate in the MOVE program through the duration of Interval #1 and Interval #3.
  • Subjects whose legal guardians are unwilling to cooperate with the requests to obtain and review healthcare records and expenditures from the subject's primary (and secondary, if applicable) payors.

ADULTS: Inclusion Criteria

  • Males and females 22-65 years old.
  • Participated in the MOVE program during Interval #1 and Interval #3.
  • Did not participate for at least 4 months in the MOVE program during Interval #2.
  • Has a healthcare payor(s) who makes healthcare records available upon request.
  • Subjects who are willing to give informed consent and/or subjects' legal guardians who are willing to give informed assent to obtain and review healthcare records from the subject's primary (and secondary, if applicable) payors.

ADULTS: Exclusion Criteria

  • Subjects who did not participate in the MOVE program through the duration of Interval #1 and Interval #3.
  • Subjects who are unwilling to give informed consent and/or subjects' legal guardians who are unwilling to give informed assent to cooperate with the requests to obtain and review healthcare records and expenditures from the subject's primary (and secondary, if applicable) payors.

Trial locations and contacts

1 site in 1 country.

Eric H Ledet, Ph.D. contact

5184375584

eric.ledet@cfdsny.org

United States1 site, 1 recruiting
  • Center for Disability Services

    Albany, New York, 12208

    Eric H Ledet, Ph.D., 518-437-5584, eric.ledet@cfdsny.org

    Rebecca Levy, MS, levyr2@rpi.edu

    Recruiting

Other trials in United States

About this study

The purpose of this study is to determine whether participation in the Mobility Opportunities Via Education (MOVE) program is associated with reduced use of healthcare for individuals with developmental disabilities.

Read the detailed description

The purpose of this study is to determine whether participation in the Mobility Opportunities Via Education (MOVE) program is associated with reduced use of healthcare for individuals with developmental disabilities. The investigators will compare healthcare "events" and healthcare expenditures for children and adults during intervals of at least one year when the subjects were participating in the MOVE program versus intervals of at least one year when the same individuals were not participating in the MOVE program based on health insurance records (i.e. Medicaid). Healthcare events are those which required professional medical services (associated with International Classification of Disease (ICD-XX) codes) or prescription medications. Healthcare events and healthcare expenditures will be reviewed from healthcare records obtained by Medicaid, Medicare, or private insurers and data will be compared between intervals.

Being tested
MOVE Program
Medical subject headings
Patient Acceptance of Health Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MOVE ProgramOther

    Mobility Opportunities Via Education functional therapy program.

Study groups in NCT05862662
Study groupRoleWhat they receive
Children in MOVE ProgramChildren 5-12 years old who participated in the MOVE program for at least 12 continuous months prior to March 1, 2020 and again for at least 12 continuous months after August 2021.
Receives: Other: MOVE Program
Adults in MOVE ProgramAdults 22-65 years old who participated in the MOVE program for at least 12 continuous months prior to March 1, 2020 and again for at least 12 continuous months after August 2021.
Receives: Other: MOVE Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sum of Disability Adjusted Life Years

    Healthcare events will be reviewed from the insurance record. International Classification of Disease (ICD) codes will be use to convert the healthcare event to disability adjusted life years. The sum of all disability adjusted life years will be calculated.

    Measured: March 1, 2019 - April 30, 2023

  2. Number of Healthcare Events

    Healthcare events will be reviewed from the insurance record. The number of visits for professional healthcare will be determined.

    Measured: March 1, 2019 - April 30, 2023

  3. Cost of Healthcare Events

    Healthcare events will be reviewed from the insurance record and total costs associated with healthcare utilization will be determined.

    Measured: March 1, 2019 - April 30, 2023

  4. Cost of Medication Use

    Insurance records will be reviewed and the cost of medication used will be determined.

    Measured: March 1, 2019 - April 30, 2023

  5. Hip Range of Motion (Degrees)

    From the Mobility Opportunities Via Education (MOVE) program records, hip range of motion (in degrees) will be determined.

    Measured: March 1, 2019 - April 30, 2023

  6. PedsQL Quality of Life Scale Score

    From the Mobility Opportunities Via Education (MOVE) program records, the Pediatric Quality of Life Inventory (PedsQL) outcome instrument will be used to determine quality of life. The PedsQL is comprised of 7 questions with each question scored on a scale of 0-4. Higher scores indicate a higher quality of life.

    Measured: March 1, 2019 - April 30, 2023

  7. Top Down Motor Milestone Test Score

    From the Mobility Opportunities Via Education (MOVE) program records, the Top Down Motor Milestone (TDMMT) score will be determined as an assessment of function

    Measured: March 1, 2019 - April 30, 2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2023
  2. Study start3 Apr 2023
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05862662
Sponsor's protocol ID
21-003 Rev. B
Status last verified
May 2023
First submitted
13 Apr 2023
Last updated
17 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Quality of Life and Health Care Utilization, run by Center for Disability Services, New York at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eric H Ledet, Ph.D. (5184375584, eric.ledet@cfdsny.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sum of Disability Adjusted Life Years (time frame: March 1, 2019 - April 30, 2023). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in